 - Prior therapy with an anti-programmed cell death PD-1, anti-PD-ligand 1 anti-PD-L1, anti-PD-L2 agent, or any agent directed to another stimulatory or inhibitory T-cell receptor eg, cytotoxic lymphocyte associated protein-4 CTLA-4, OX-40, CD137 